Volume 211 - Issue 6

Pulmonary tumour thrombotic microangiopathy: a rare but underappreciated complication of malignancy

Authors:  Pakeeran Siriratnam and Vishal Boolell

Med J Aust 2019; 211 (6): 257-257.e1. || doi: 10.5694/mja2.50305
Published online: 16 September 2019

A 36-year-old man presented with a syncopal episode and worsening dyspnoea over the previous 3 days

A 36-year-old man presented with a syncopal episode and worsening dyspnoea over the previous 3 days. He had recently been diagnosed elsewhere with poorly differentiated metastatic carcinoma. Our examination and imaging revealed severe right heart failure and pulmonary hypertension. He died within hours of his presentation. A subsequent autopsy revealed a diagnosis of pulmonary tumour thrombotic microangiopathy, which is mostly associated with carcinomas and is characterised by microemboli formation in the pulmonary vasculature.1 The histopathology from autopsy showed an arteriole with a tumour embolus associated with the fibrin (Figure, A) and fibrous intimal hyperplasia nearly occluding the lumen of these vessels (Figure, B). The acute and rapid nature of the condition makes antemortem diagnosis a significant challenge, although present in 3.3% of cases of carcinomas at post mortem examination.1,2 While there are no guidelines on management, case series describe imatinib, chemotherapy or targeted therapy aimed at the primary malignancy, or corticosteroid therapy as potential options.1,2


Authors


Competing interests


References


More like this

Cancer Research 18 August 2026 Open Access

Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study

Evangeline Samuel, Eldho Paul, Mike Lloyd, Sanuki Tissera, Craig Underhill, Sagun Parakh, Phillip Parente, Inger Olesen, Javier Torres, Katharine See, Gavin M. Wright, David Langton, Thomas John, Matthew Conron, James Bartlett, Nicola Atkin, Nikolajs Zeps, Susan V. Harden, Wasek Faisal, John R. Zalcberg, Rob G. Stirling

Cancer Research 18 August 2026 Open Access

Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009–2024) to Guide Treatment Planning

Savio G. Barreto, Christos S. Karapetis, Shahid Ullah, Matthew Burge, Susan Caird, Angus Campbell, Azim Jalali, Ross Jennens, Muhammad A. Khattak, Belinda Lee, Stephanie H. Lim, Shehara Mendis, Louise Nott, Timothy J. Price, Jeremy D. Shapiro, Jeanne Tie, Javier Torres, Colin Williams, Rachel Wong, Vanessa Wong, Peter Gibbs

Cancer Guideline summary 13 July 2026 Open Access

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia

Nicole M. Rankin, Rebecca Zosel, Lisa J. Whop, Raglan Maddox, Annette McWilliams, Miranda Siemienowicz, Jon Emery, Maria A. R. Lantin, Georgia Bartlett, Mikayla Wolfe, Abbey Diaz, Katrina Anderson, Lillian Liu, Cindy Toms, Sarah McDermott, Peter Bligh, Jeremy Chalke, Stephen Melsom, Claire E. Nightingale, Alison Brown, Sam Pope, Julia Brotherton, Anne Fidler, Michel Itel, Mark Brooke, Diane M. Pascoe, Fraser Brims, Tracy L. Leong, Emily Stone, Dorothy Keefe, Vivienne Milch